Do you want to read an article? Please log in or register.
Systemic Drugs Associated With Maculopathy
Further Publications
Related content
Further Publications
Drugs Associated with Floppy Iris Syndrome: A Real-World Population-Based Study: Drugs Associated with Floppy Iris Syndrome
Am J Ophthalmol
Lakhani M, Kwan ATH, Mihalache A, Popovic MM, Hurley B, Muni RH
doi: 10.1016/j.ajo.2025.03.023
Macular DiseasesRetinal Diseases
Systemic and ocular associated factors for pathologic myopia in a highly myopic Chinese population: findings from the Wenzhou pathologic myopia study
Br J Ophthalmol
Zhao J, Gong Q, Jiang Y, Han J, Zhu X, Li M, Lu F, Hu L
doi: 10.1136/bjo-2025-327438
Uveitis
Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports
Surv Ophthalmol
Ghalibafan S, Herskowitz WR, Chou BG, Rohowetz LJ, Gutkind NE, Llop SM, Yannuzzi NA
doi: 10.1016/j.survophthal.2025.09.021
Further Publications
Pentosan Polysulfate Maculopathy Following Subcutaneous Injections for Arthritis
JAMA Ophthalmol
Fung AT, Sarraf D, Carrillo JM, Feo A, Faghihi S, Borie CM, Lim L, Hunyor AP, Yannuzzi NA
doi: 10.1001/jamaophthalmol.2025.5069
Retinal Diseases
Progression of hydroxychloroquine-induced retinopathy after drug cessation
Graefes Arch Clin Exp Ophthalmol
Brown RB, Kitay AM, Driban M, Zur D, Kniestedt C, Barthelmes D, Sadeghi E, Chhablani JK, Al-Sheikh M
doi: 10.1007/s00417-025-07037-8
Further Publications
Systemic and Metabolic Profile of Sagging Eye Syndrome: A Comparative Analysis
Am J Ophthalmol
Yehezkeli V, Kim JJ, Velez FG, Demer JL, Pineles SL
doi: 10.1016/j.ajo.2025.11.040
RECOMMENDED
Macular Diseases
Risk and Dose-Response Relationship for Pentosan Polysulfate Sodium Maculopathy: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Tao BK, Sawires K, Lim K, Butt F, Dhivagaran T, Gupta RR, Mishra A
doi: 10.1016/j.oret.2025.03.001
Further Publications
Comparative Analysis of Ocular Adverse Events Associated with Aflibercept 8 mg and Faricimab: A Global Population-Based Study Across 65 Countries
Ophthalmol Retina
Lakhani M, Popovic MM, Al-Ani A, Kundapur D, Gholamian T, Chaudry E, Nanji K, Patil N, Feo A, Sadda S, Sarraf D, Ip MS, Kertes PJ, Muni RH, Adatia F, Damji KF, Chaudhary V, Hurley BR
doi: 10.1016/j.oret.2025.10.019
Macular Diseases
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration
JAMA Ophthalmol
Lynch AM, Grove NC, Wagner BD, Palestine AG, Holers VM, Frazer-Abel AA, Gnanaraj R, Lisker-Cervantes A, Patnaik JL, de Carlo Forest TE, Auer EA, McReynolds AJ, Mathias MT, Manoharan N, Rodriquez De Cordoba S, Mandava N
doi: 10.1001/jamaophthalmol.2025.1608